Menu
Home
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Misc
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Labrish
Nyuuz
DOJ targets anti-Israel protesters under FACE Act in New Jersey
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
[QUOTE="Munyaradzi Mafaro, post: 63095, member: 636"] The Justice Department filed a civil lawsuit against anti-Israeli demonstrators under a 1994 law originally designed to safeguard abortion clinic access. Assistant Attorney General Harmeet Dhillon announced the case Monday and indicated more lawsuits may follow. She stated the Freedom of Access to Clinic Entrances Act had been misused against pro-life activists while ignoring disruptions of religious activities. The lawsuit addresses a November 2024 incident at a New Jersey synagogue hosting a West Bank settlement real estate event. About 50 pro-Palestinian protesters gathered outside, leading to a confrontation with organizers Moshe Glick and David Silberberg. Prosecutors claim a protester attacked Glick with a vuvuzela horn at close range, potentially causing hearing damage. Local reports indicate Glick and Silberberg faced charges after Glick pepper-sprayed a protester and struck him with a flashlight. The Justice Department maintains they acted in self-defense during the altercation. [/QUOTE]
Insert quotes…
Name
Post reply
Home
Forums
Labrish
Nyuuz
DOJ targets anti-Israel protesters under FACE Act in New Jersey
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top